Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2016-10-31

FDA Approved: ALLEGRA-D ALLERGY AND CONGESTION — Supplemental Application (Chattem, Inc.)

View source ↗

Summary

FDA approved a supplemental application for Allegra-D Allergy and Congestion, a combination product from Chattem, Inc. containing fexofenadine hydrochloride and…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ALLEGRA-D ALLERGY AND CONGESTION (Fexofenadine hydrochloride and pseudoephedrine hydrochloride)

Snippet

SUPPL AP for ALLEGRA-D ALLERGY AND CONGESTION (FEXOFENADINE HYDROCHLORIDE AND PSEUDOEPHEDRINE HYDROCHLORIDE)